Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Public Advisory - Counterfeit Viagra and Cialis erectile dysfunction drugs seized from Grace Daily Mart in Scarborough, Ontario


OTTAWA, ON, Aug. 25, 2022 /CNW/ - 

Summary

Image(s)

Public Advisory  - Counterfeit Viagra and Cialis erectile dysfunction drugs seized from Grace Daily Mart in Scarborough, Ontario (CNW Group/Health Canada)

Public Advisory  - Counterfeit Viagra and Cialis erectile dysfunction drugs seized from Grace Daily Mart in Scarborough, Ontario (CNW Group/Health Canada)

Public Advisory  - Counterfeit Viagra and Cialis erectile dysfunction drugs seized from Grace Daily Mart in Scarborough, Ontario (CNW Group/Health Canada)

Public Advisory  - Counterfeit Viagra and Cialis erectile dysfunction drugs seized from Grace Daily Mart in Scarborough, Ontario (CNW Group/Health Canada)

Affected products

Product

Lot

Expiry date

Counterfeit Viagra (Pfizer)

unknown

2025-03

Counterfeit Cialis (Eli Lilly)

05668

2024-04

 

Issue

Health Canada inspectors seized counterfeit Viagra and Cialis erectile dysfunction drugs from the Grace Daily Mart in Scarborough, Ontario (1579 Ellesmere Road). These products are in addition to several other unauthorised sexual enhancement products that Health Canada seized from the same location.  

The seized Viagra is labelled with an expiry date 2025-03 and the seized Cialis is labelled with lot 05668 and expiry 2024-04. Both were sold in individual blister packs with no other packaging. Health Canada has confirmed with Pfizer, the manufacturer of Viagra, as well as Eli Lilly, the manufacturer of Cialis, that the seized products are counterfeit.

Counterfeit drugs are made to look like authentic products, but they may not be the same and they can pose serious health risks. For example, they could contain a higher dosage than shown on the label, contaminants or hidden dangerous ingredients, that can seriously harm your health. On the other hand, they might not contain the drug at all. Unlike authorized and authentic drug products, counterfeit drugs have not been assessed by Health Canada for safety, effectiveness and quality. Selling counterfeit health products in Canada is illegal.

According to the packaging, the counterfeit Viagra?like authentic Viagra?is labelled to contain the prescription drug sildenafil, while the counterfeit Cialis?like authentic Cialis?is labelled to contain the prescription drug tadalafil. Both drugs can pose serious health risks, especially when not taken as prescribed by a health care professional, particularly for people with heart problems or taking nitrate drugs (e.g., nitroglycerin).

Health Canada reminds the public that the best way to make sure their prescription drug is authentic is to buy it from a licensed pharmacy. Moreover, prescription drugs should be taken only under the advice and supervision of a health care professional because they are used to treat specific health conditions and may cause serious side effects.

What you should do
Background

Sildenafil and tadalafil are prescription drugs used to treat erectile dysfunction and should be used only under the supervision of a health care professional. The drugs should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerin) as they can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure and abnormal heartbeat. Other possible side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss.

Alert / recall type: Public Advisory
Category: Health products ? Drugs
Published by: Health Canada

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: